ClinicalTrials.gg
Sign In

Minghui Pharmaceutical (Hangzhou) Ltd clinical trials

A subsidiary of Minghui Pharmaceutical

The registry lists 20 studies whose lead sponsor is Minghui Pharmaceutical (Hangzhou) Ltd. 13 are recruiting or about to start. Per ClinicalTrials.gov, last updated Oct 16, 2026.

What it is testing

The drugs Minghui Pharmaceutical (Hangzhou) Ltd’s studies test, most open studies first — 5 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Coming up

3 of Minghui Pharmaceutical (Hangzhou) Ltd’s studies under way reach primary completion within a year, 2 of them phase 3. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. 1D
  3. J’27
  4. F
  5. M
  6. 1A
  7. M
  8. J
  9. J
  10. 1A
  11. S
  12. O
  13. N

All 3

Add all 3 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting2

All 20 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now1365%Recruiting 12 · Not yet recruiting 1
  • Under way, not recruiting420%
  • Completed315%

Phase

  • Phase 211
  • Phase 110
  • Phase 38

Where

  • China17
  • United States2

Over the years

  1. 22
  2. 23
  3. 24
  4. 725
  5. 726

By the year each study started. 2026 so far in the lighter column.

Registry sponsor names on this page

  • Minghui Pharmaceutical (Hangzhou) Ltd20 studies

Something wrong with this grouping? Tell us on the Minghui Pharmaceutical page.

Studies

Recruiting first, then most recently updated. Showing 20 of 20. All Minghui Pharmaceutical studies →